1
|
Gomes AR, Varela CL, Pires AS, Tavares-da-Silva EJ, Roleira FMF. Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review. Bioorg Chem 2023; 138:106600. [PMID: 37209561 DOI: 10.1016/j.bioorg.2023.106600] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Revised: 04/15/2023] [Accepted: 05/05/2023] [Indexed: 05/22/2023]
Abstract
Guanidines are fascinating small nitrogen-rich organic compounds, which have been frequently associated with a wide range of biological activities. This is mainly due to their interesting chemical features. For these reasons, for the past decades, researchers have been synthesizing and evaluating guanidine derivatives. In fact, there are currently on the market several guanidine-bearing drugs. Given the broad panoply of pharmacological activities displayed by guanidine compounds, in this review, we chose to focus on antitumor, antibacterial, antiviral, antifungal, and antiprotozoal activities presented by several natural and synthetic guanidine derivatives, which are undergoing preclinical and clinical studies from January 2010 to January 2023. Moreover, we also present guanidine-containing drugs currently in the market for the treatment of cancer and several infectious diseases. In the preclinical and clinical setting, most of the synthesized and natural guanidine derivatives are being evaluated as antitumor and antibacterial agents. Even though DNA is the most known target of this type of compounds, their cytotoxicity also involves several other different mechanisms, such as interference with bacterial cell membranes, reactive oxygen species (ROS) formation, mitochondrial-mediated apoptosis, mediated-Rac1 inhibition, among others. As for the compounds already used as pharmacological drugs, their main application is in the treatment of different types of cancer, such as breast, lung, prostate, and leukemia. Guanidine-containing drugs are also being used for the treatment of bacterial, antiprotozoal, antiviral infections and, recently, have been proposed for the treatment of COVID-19. To conclude, the guanidine group is a privileged scaffold in drug design. Its remarkable cytotoxic activities, especially in the field of oncology, still make it suitable for a deeper investigation to afford more efficient and target-specific drugs.
Collapse
Affiliation(s)
- Ana R Gomes
- Univ Coimbra, CIEPQPF, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal; Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal
| | - Carla L Varela
- Clinical Academic Center of Coimbra (CACC), Praceta Professor Mota Pinto, 3004-561 Coimbra, Portugal; Univ Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Rua Larga, 3004-504 Coimbra, Portugal; Univ Coimbra, CIEPQPF, Faculty of Medicine, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal
| | - Ana S Pires
- Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal; Clinical Academic Center of Coimbra (CACC), Praceta Professor Mota Pinto, 3004-561 Coimbra, Portugal; Univ Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Rua Larga, 3004-504 Coimbra, Portugal
| | - Elisiário J Tavares-da-Silva
- Univ Coimbra, CIEPQPF, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal.
| | - Fernanda M F Roleira
- Univ Coimbra, CIEPQPF, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Azinhaga de Santa Comba, Pólo III - Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal.
| |
Collapse
|
2
|
Ischay MA, Hoang B, Steinhuebel DP, Chin MR, Dixon DD, Elfgren D, Heumann L, Lew W, Mundal DA, Neville ST, Shah NP, Shi B, Tripp JC, Wang Q. Process Development and Scale-Up of a Protease Inhibitor for the Treatment of HIV Featuring the Preparation of a Neopentyl Grignard Reagent and Development of a One-Pot Curtius Reaction. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00153] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Michael A. Ischay
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Brittanie Hoang
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Dietrich P. Steinhuebel
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Matthew R. Chin
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Darryl D. Dixon
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Danielle Elfgren
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Lars Heumann
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Willard Lew
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Devon A. Mundal
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Sean T. Neville
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Nisha P. Shah
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Bing Shi
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Jonathan C. Tripp
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| | - Queenie Wang
- Department of Process Chemistry, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States
| |
Collapse
|
3
|
Zuo S, Zhang F, Liu J, Zuo A. Synthesis of bis(2-imino-1,3-dimethylbenzimidazoline)s via reactions of a solvothermally prepared benzimidazolium chloride and diamines. Tetrahedron Lett 2021. [DOI: 10.1016/j.tetlet.2021.152920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
4
|
Nafie MS, Arafa K, Sedky NK, Alakhdar AA, Arafa RK. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer. Chem Biol Interact 2020; 324:109087. [PMID: 32294457 DOI: 10.1016/j.cbi.2020.109087] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Revised: 03/17/2020] [Accepted: 04/02/2020] [Indexed: 12/18/2022]
Abstract
Despite advances in cancer treatment modalities, DNA still stands as one of the targets for anticancer agents. DNA minor groove binders (MGBs) represent an important investigational chemotherapeutic class with promising cytotoxic capacity. Herein this study reports the potent cytotoxic effect of a series of repurposed flexible bis-imidamides 1-4, triaryl bis-guanidine 5 and bis-N-substituted guanidines 6,7 having a 1,4-diphenoxybenzene scaffold backbone on MCF-7 and MDA-MB-231 breast cancer cell lines. Of these compounds, imidamide 4 was chosen for further in-vitro, in-vivo and molecular dynamics (MD) studies owing to its promising anti-tumor activity, with IC50 values on MCF-7 and MDA-MB-231 breast cancer cell lines of 1.9 and 2.08 μM, respectively. Annexin V/propidium iodide apoptosis assay revealed apoptosis induction on imidamide 4 treated MCF-7 cells. RT-PCR assay results demonstrated the proapoptotic effect of compound 4 through increase of mRNA levels of the pro-apoptotic genes; p53, PUMA, and Bax, and inhibiting the anti-apoptotic Bcl-2 gene expression in MCF-7 cells. Moreover, compound 4 induced a G0/G1 cell-cycle arrest in MCF-7 in a dose-dependent manner. Corroborating in-vivo experiments on Ehrlich ascites carcinoma (EAC)-bearing mice, reflected the anticancer strength of derivative 4. For further target validation, molecular dynamics (MD) studies demonstrated an energetically favorable binding of imidamide 4 with the DNA minor groove AT rich site. In effect, imidamide 4 can be viewed as a promising hit dicationic compound with good cytotoxic and apoptotic inducing activity against breast cancer that can be adopted for future optimization.
Collapse
Affiliation(s)
- Mohamed S Nafie
- Chemistry Department, Faculty of Science Suez Canal University, Ismailia, 41522, Egypt
| | - Kholoud Arafa
- Center for Materials Science, Zewail City of Science and Technology, 12578, Cairo, Egypt
| | - Nada K Sedky
- Drug Design and Discovery Laboratory, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, 12578, Cairo, Egypt; Biochemistry Department, Faculty of Pharmacy, Sinai University, East Kantara Branch, New City, El Ismailia, 41611, Cairo, Egypt
| | - Amira A Alakhdar
- Drug Design and Discovery Laboratory, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, 12578, Cairo, Egypt
| | - Reem K Arafa
- Drug Design and Discovery Laboratory, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, 12578, Cairo, Egypt; Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, 12578, Cairo, Egypt.
| |
Collapse
|
5
|
Rahman A, O'Sullivan P, Rozas I. Recent developments in compounds acting in the DNA minor groove. MEDCHEMCOMM 2018; 10:26-40. [PMID: 30774852 DOI: 10.1039/c8md00425k] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Accepted: 12/11/2018] [Indexed: 12/12/2022]
Abstract
The macromolecule that carries genetic information, DNA, is considered as an exceptional target for diseases depending on cellular division of malignant cells (i.e. cancer), microbes (i.e. bacteria) or parasites (i.e. protozoa). To aim for a comprehensive review to cover all aspects related to DNA targeting would be an impossible task and, hence, the objective of the present review is to present, from a medicinal chemistry point of view, recent developments of compounds targeting the minor groove of DNA. Accordingly, we discuss the medicinal chemistry aspects of heterocyclic small-molecules binding the DNA minor groove, as novel anticancer, antibacterial and antiparasitic agents.
Collapse
Affiliation(s)
- Adeyemi Rahman
- School of Chemistry , Trinity Biomedical Sciences Institute , Trinity College Dublin , 152-160-Pearse Street , Dublin 2 , Ireland .
| | - Patrick O'Sullivan
- School of Chemistry , Trinity Biomedical Sciences Institute , Trinity College Dublin , 152-160-Pearse Street , Dublin 2 , Ireland .
| | - Isabel Rozas
- School of Chemistry , Trinity Biomedical Sciences Institute , Trinity College Dublin , 152-160-Pearse Street , Dublin 2 , Ireland .
| |
Collapse
|
6
|
Bhaduri S, Ranjan N, Arya DP. An overview of recent advances in duplex DNA recognition by small molecules. Beilstein J Org Chem 2018; 14:1051-1086. [PMID: 29977379 PMCID: PMC6009268 DOI: 10.3762/bjoc.14.93] [Citation(s) in RCA: 70] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2017] [Accepted: 04/06/2018] [Indexed: 12/13/2022] Open
Abstract
As the carrier of genetic information, the DNA double helix interacts with many natural ligands during the cell cycle, and is amenable to such intervention in diseases such as cancer biogenesis. Proteins bind DNA in a site-specific manner, not only distinguishing between the geometry of the major and minor grooves, but also by making close contacts with individual bases within the local helix architecture. Over the last four decades, much research has been reported on the development of small non-natural ligands as therapeutics to either block, or in some cases, mimic a DNA–protein interaction of interest. This review presents the latest findings in the pursuit of novel synthetic DNA binders. This article provides recent coverage of major strategies (such as groove recognition, intercalation and cross-linking) adopted in the duplex DNA recognition by small molecules, with an emphasis on major works of the past few years.
Collapse
Affiliation(s)
| | - Nihar Ranjan
- National Institute of Pharmaceutical Education and Research (NIPER), Raebareli 122003, India
| | - Dev P Arya
- NUBAD, LLC, 900B West Faris Rd., Greenville 29605, SC, USA.,Clemson University, Hunter Laboratory, Clemson 29634, SC, USA
| |
Collapse
|
7
|
Isouronium and N -hydroxyguanidinium derivatives as Cell growth inhibitors: A comparative study. Eur J Med Chem 2016; 117:269-82. [DOI: 10.1016/j.ejmech.2016.03.047] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2015] [Revised: 03/16/2016] [Accepted: 03/17/2016] [Indexed: 12/21/2022]
|
8
|
Nieto D, Bruña S, González-Vadillo AM, Perles J, Carrillo-Hermosilla F, Antiñolo A, Padrón JM, Plata GB, Cuadrado I. Catalytically Generated Ferrocene-Containing Guanidines as Efficient Precursors for New Redox-Active Heterometallic Platinum(II) Complexes with Anticancer Activity. Organometallics 2015. [DOI: 10.1021/acs.organomet.5b00751] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Daniel Nieto
- Departamento
de Quı́mica Inorgánica, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| | - Sonia Bruña
- Departamento
de Quı́mica Inorgánica, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| | - Ana M González-Vadillo
- Departamento
de Quı́mica Inorgánica, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| | - Josefina Perles
- Servicio
Interdepartamental de Investigación (SIdI), Laboratorio de
Difracción de Rayos X de Monocrystal, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| | - Fernando Carrillo-Hermosilla
- Centro
de Innovación en Quı́mica Avanzada (ORFEO-CINQA),
Departamento de Quı́mica Inorgánica, Orgánica
y Bioquı́mica, Facultad de Ciencias y Tecnologı́as
Quı́micas, Universidad de Castilla La Mancha, 13071 Ciudad Real, Spain
| | - Antonio Antiñolo
- Centro
de Innovación en Quı́mica Avanzada (ORFEO-CINQA),
Departamento de Quı́mica Inorgánica, Orgánica
y Bioquı́mica, Facultad de Ciencias y Tecnologı́as
Quı́micas, Universidad de Castilla La Mancha, 13071 Ciudad Real, Spain
| | - José M. Padrón
- BioLab,
Instituto Universitario de Bio-Orgánica Antonio González
(IUBO-AG), Centro de Investigaciones Biomédicas de Canarias
(CIBICAN), Universidad de La Laguna, 38206 La Laguna, Spain
| | - Gabriela B. Plata
- BioLab,
Instituto Universitario de Bio-Orgánica Antonio González
(IUBO-AG), Centro de Investigaciones Biomédicas de Canarias
(CIBICAN), Universidad de La Laguna, 38206 La Laguna, Spain
| | - Isabel Cuadrado
- Departamento
de Quı́mica Inorgánica, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| |
Collapse
|
9
|
Ríos Martínez CH, Lagartera L, Trujillo C, Dardonville C. Bisimidazoline arylamides binding to the DNA minor groove: N1-hydroxylation enhances binding affinity and selectivity to AATT sites. MEDCHEMCOMM 2015. [DOI: 10.1039/c5md00292c] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Selective binding of N-hydroxy bisimidazolines to dsDNA GCAATTGC is derived from a tighter fit to this narrower minor groove.
Collapse
Affiliation(s)
| | | | - Cristina Trujillo
- School of Chemistry
- Trinity Biomedical Sciences Institute
- Trinity College Dublin
- Dublin 2
- Ireland
| | | |
Collapse
|
10
|
Shaw JW, Grayson DH, Rozas I. Synthesis of Guanidines and Some of Their Biological Applications. TOPICS IN HETEROCYCLIC CHEMISTRY 2015. [DOI: 10.1007/7081_2015_174] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
11
|
Guanidinium-based derivatives: Searching for new kinase inhibitors. Eur J Med Chem 2014; 81:427-41. [DOI: 10.1016/j.ejmech.2014.05.025] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2014] [Revised: 03/20/2014] [Accepted: 05/06/2014] [Indexed: 01/07/2023]
|
12
|
Ríos Martínez CH, Lagartera L, Kaiser M, Dardonville C. Antiprotozoal activity and DNA binding of N-substituted N-phenylbenzamide and 1,3-diphenylurea bisguanidines. Eur J Med Chem 2014; 81:481-91. [PMID: 24865793 DOI: 10.1016/j.ejmech.2014.04.083] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2014] [Revised: 04/29/2014] [Accepted: 04/30/2014] [Indexed: 10/25/2022]
Abstract
Two series of N-alkyl, N-alkoxy, and N-hydroxy bisguanidines derived from the N-phenylbenzamide and 1,3-diphenylurea scaffolds were synthesised in three steps from the corresponding 4-amino-N-(4-aminophenyl)benzamide and 1,3-bis(4-aminophenyl)urea, respectively. All of the new compounds were evaluated in vitro against T. b. rhodesiense (STIB900) trypomastigotes and Plasmodium falciparum NF54 parasites (erythrocytic stage). N-alkoxy and N-hydroxy derivatives showed weak micromolar range IC50 values against T. b. rhodesiense and P. falciparum whereas the N-alkyl analogues displayed submicromolar and low nanomolar IC50 values against P. falciparum and Trypanosoma brucei, respectively. Two compounds, 4-(2-ethylguanidino)-N-(4-(2-ethylguanidino)phenyl)benzamide dihydrochloride (7b) and 4-(2-isopropylguanidino)-N-(4-(2-isopropylguanidino)phenyl)benzamide dihydrochloride (7c), which showed favourable drug-like properties and in vivo efficacy (100% cures) in the STIB900 mouse model of acute human African trypanosomiasis represent interesting leads for further in vivo studies. The binding of these compounds to AT-rich DNA was confirmed by surface plasmon resonance (SPR) biosensor experiments.
Collapse
Affiliation(s)
| | - Laura Lagartera
- Instituto de Química Médica, IQM-CSIC, Juan de la Cierva 3, E-28006 Madrid, Spain
| | - Marcel Kaiser
- Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland; University of Basel, Basel, Switzerland
| | | |
Collapse
|